产品标题 |
产品货号 |
产品规格 |
厂家 |
ADD3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH311957 | 10 ug | ORIGENE TECHNOLOGIES |
ADD3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309129 | 10 ug | ORIGENE TECHNOLOGIES |
Adducin 1 (alpha) (ADD1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420118 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 1 (alpha) (ADD1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY406127 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 1 (alpha) (ADD1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY415438 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 2 (beta) (ADD2), transcript variant beta-1 from ORIGENE TECHNOLOGIES | LY419845 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 2 (beta) (ADD2), transcript variant beta-2 from ORIGENE TECHNOLOGIES | LY429539 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 2 (beta) (ADD2), transcript variant beta-2 from ORIGENE TECHNOLOGIES | LY413766 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 2 (beta) (ADD2), transcript variant beta-4 from ORIGENE TECHNOLOGIES | LY413769 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 3 (gamma) (ADD3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402581 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 3 (gamma) (ADD3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420120 | 100 ug | ORIGENE TECHNOLOGIES |
Adducin 3 (gamma) (ADD3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426532 | 100 ug | ORIGENE TECHNOLOGIES |
Adenine phosphoribosyltransferase (APRT), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424695 | 100 ug | ORIGENE TECHNOLOGIES |
Adenine phosphoribosyltransferase (APRT), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422236 | 100 ug | ORIGENE TECHNOLOGIES |
Adenine phosphoribosyltransferase (APRT), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425509 | 100 ug | ORIGENE TECHNOLOGIES |
Adenomatosis polyposis coli down-regulated 1 (APCDD1) from ORIGENE TECHNOLOGIES | LY403498 | 100 ug | ORIGENE TECHNOLOGIES |
Adenomatosis polyposis coli down-regulated 1-like (APCDD1L) from ORIGENE TECHNOLOGIES | LY407073 | 100 ug | ORIGENE TECHNOLOGIES |
Adenomatous polyposis coli (APC), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426808 | 100 ug | ORIGENE TECHNOLOGIES |
Adenomatous polyposis coli (APC), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426807 | 100 ug | ORIGENE TECHNOLOGIES |
Adenosylhomocysteinase-like 1 (AHCYL1) from ORIGENE TECHNOLOGIES | LY416510 | 100 ug | ORIGENE TECHNOLOGIES |
Adenosylhomocysteinase-like 2 (AHCYL2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414625 | 100 ug | ORIGENE TECHNOLOGIES |
Adenosylhomocysteinase-like 2 (AHCYL2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427264 | 100 ug | ORIGENE TECHNOLOGIES |
Adenosylmethionine decarboxylase 1 (AMD1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419830 | 100 ug | ORIGENE TECHNOLOGIES |
Adenovirus IgA ELISA Kit from ORIGENE TECHNOLOGIES | EA101048 | 96-well strip plate | ORIGENE TECHNOLOGIES |
Adenovirus IgG ELISA Kit from ORIGENE TECHNOLOGIES | EA101049 | 96-well strip plate | ORIGENE TECHNOLOGIES |
Adenovirus IgM ELISA Kit from ORIGENE TECHNOLOGIES | EA101050 | 96-well strip plate | ORIGENE TECHNOLOGIES |
Adenylate cyclase activating polypeptide 1 (pituitary) (ADCYAP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420506 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase activating polypeptide 1 (pituitary) (ADCYAP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426082 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase activating polypeptide 1 (pituitary) (ADCYAP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400450 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase 3 (ADCY3) from ORIGENE TECHNOLOGIES | LY418293 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase 7 (ADCY7) from ORIGENE TECHNOLOGIES | LY420130 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase 1 (brain) (ADCY1) from ORIGENE TECHNOLOGIES | LY412077 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase 2 (brain) (ADCY2) from ORIGENE TECHNOLOGIES | LY412417 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate cyclase 8 (brain) (ADCY8) from ORIGENE TECHNOLOGIES | LY420131 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 1 (AK1) from ORIGENE TECHNOLOGIES | LY400171 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 7 (AK7) from ORIGENE TECHNOLOGIES | LY407632 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 3 (AK3), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY414079 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 5 (AK5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403569 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 5 (AK5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415983 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 2 (AK2), transcript variant AK2A from ORIGENE TECHNOLOGIES | LY419835 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 2 (AK2), transcript variant AK2B from ORIGENE TECHNOLOGIES | LY415600 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 2 (AK2), transcript variant AK2B from ORIGENE TECHNOLOGIES | LY429382 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase domain containing 1 (AKD1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408086 | 100 ug | ORIGENE TECHNOLOGIES |
Adenylate kinase 3-like 1 (AK3L1), nuclear gene encoding mitochondrial protein, transcript variant 5 from ORIGENE TECHNOLOGIES | LY423694 | 100 ug | ORIGENE TECHNOLOGIES |
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS547293 | 5x5um | ORIGENE TECHNOLOGIES |
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS547295 | 5x5um | ORIGENE TECHNOLOGIES |
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS548279 | 5x5um | ORIGENE TECHNOLOGIES |
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS548280 | 5x5um | ORIGENE TECHNOLOGIES |
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS548281 | 5x5um | ORIGENE TECHNOLOGIES |
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS548460 | 5x5um | ORIGENE TECHNOLOGIES |